No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs565798546 |
chr19:56727323-56727324 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs528080589 |
chr19:56727371-56727372 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs7247056 |
chr19:56727401-56727402 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs191520532 |
chr19:56727433-56727434 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs535524277 |
chr19:56727441-56727442 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs557491114 |
chr19:56727449-56727450 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs142551685 |
chr19:56727474-56727475 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs552769620 |
chr19:56727509-56727510 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs78714335 |
chr19:56727510-56727511 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs536878316 |
chr19:56727511-56727512 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs79851675 |
chr19:56727512-56727513 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs373032111 |
chr19:56727525-56727526 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs79574114 |
chr19:56727555-56727556 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs544998131 |
chr19:56727570-56727571 |
Enhancers Weak transcription ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs66649854 |
chr19:56727606-56727607 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs577473652 |
chr19:56727634-56727635 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs147718003 |
chr19:56727641-56727642 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs371132033 |
chr19:56727677-56727678 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs543364319 |
chr19:56727680-56727681 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs563467681 |
chr19:56727716-56727717 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs373815174 |
chr19:56727721-56727722 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs12973406 |
chr19:56727776-56727777 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs542844508 |
chr19:56727782-56727783 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs541277617 |
chr19:56727786-56727787 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs113188879 |
chr19:56727799-56727800 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs114691975 |
chr19:56727818-56727819 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs186319668 |
chr19:56727827-56727828 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs118101022 |
chr19:56727844-56727845 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs531195401 |
chr19:56727921-56727922 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs200297202 |
chr19:56727955-56727956 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs201487013 |
chr19:56727957-56727958 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs79906766 |
chr19:56727958-56727959 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs10522110 |
chr19:56727980-56727981 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs376129129 |
chr19:56728001-56728002 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs189881007 |
chr19:56728029-56728030 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs547963989 |
chr19:56728056-56728057 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs533690720 |
chr19:56728068-56728069 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs144615042 |
chr19:56728115-56728116 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs146863526 |
chr19:56728170-56728171 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs538754466 |
chr19:56728189-56728190 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs140721389 |
chr19:56728203-56728204 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs182100992 |
chr19:56728216-56728217 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs187585014 |
chr19:56728217-56728218 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs556961971 |
chr19:56728221-56728222 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs367880036 |
chr19:56728258-56728259 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs531275425 |
chr19:56728261-56728262 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs573921202 |
chr19:56728265-56728266 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs542457884 |
chr19:56728266-56728267 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs559594413 |
chr19:56728267-56728268 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs71368885 |
chr19:56728279-56728280 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|